ALEXANDER PERKINS ●NEW— Counsel, (Senator Ron Wyden), Trade Counsel (Ways and Means Subcommittee on Trade)ALYENE MLINAR ●NEW— Pol Adv (Maj Leader Scalise); Pol Adv (Min Whip Scalise); Pol Adv (House Oversight/Govt Reform Comm); Prof Staff Member (Ways and Means Subcom on Health/Brady), Pol Adv (Sen Rep Policy Comm/Barrasso); Leg Asst (Senator Ben Sasse)ANNIE WOLF ●NEW— Dep Floor Dir (Maj Leader Scalise); CoS (Chief Dep Min Whip Ferguson); Dep Floor Dir (Min Whip Scalise); Prof Staff (House Rules/Sessions); Floor Asst (Speakers Ryan & Boehner); Staff Asst (Speaker Boehner); Intern (Rep. Sullivan)BRUCE MEHLMAN ●NEW— Asst Sec of Commerce for Tech Pol; General Csl & Pol Dir (House Repub Conf)CAITLIN VAN SANT ●NEW— Sr Pol Adv, Leg Dir, Interim COS (Rep. Butterfield)DAVID THOMAS ●NEW— CoS (Rep. Lofgren); Dir of Congressional Relations (FTC); Dep Dir for Legis Affairs (Office of VP Gore); Staff Asst (Senator Metzenbaum)DEAN ROSEN ●NEW— Health Pol Dir (Senate Maj Ldr Frist); Staff Dir (Senate Pub. Health SC); Maj Health Pol Csl (House Ways/Means C, Health SC); Health Pol Coord & Csl (Senate Labor/HR C); Csl & Prof Staff (Senate Labor/HR C, Disab Pol SC); Case Wkr (Rep. Boschwitz)ELISE FINLEY PICKERING ●NEW— Exec Dir (House Repub Pol C); CoS (Rep. Shadegg); LA (Rep. Dannemeyer); LD (Rep. Bartlett)ERICA CHABOT ●NEW— Staff Dir (Sen Ag Comm); Dep CoS (Senate Consult); LD (Sen Pres Pro Temp Emeritus); Prof Staff (Sen Approp Comm); Leg Dir, Dep Press Sec, Press Asst, Asst to COS, Asst Schd, Leg Corres, Staff Asst, (Senator Patrick Leahy)HELEN TOLAR ●NEW— CoS (Senator Boozman); Staff Dir/Chief Csl - House VA C (Rep. Miller); Prof Staff/Csl - Senate VA C (Senator Craig); Csl/LD (Rep. Miller); LA (Rep. Miller); Scheduler (Rep. Miller); Law Clerk (House Trans/Infra C)JON ADAME ●NEW— CoS, LD, GC (Sen. Blackburn); Counsel (Rep. Blackburn); Policy Coordinator (House E&C); Intern (Sen. Domenici)JOSEPH BROWN ●NEW— Sr Prof Staff (EPW Comm Maj/Sen. Moore Capito); Prof Staff (EPW Comm Min/Ranking Mem Sen. Moore Capito); Leg Asst (Sen. Boozman); Maj Leg Asst (EPW Comm Maj/Sen. Jim Inhofe); Maj Research Asst (EPW Comm Maj/Sen. Jim Inhofe); Intern (Rep. Jim Renacci)LAUREN ARONSON ●NEW— Dir (Office of Legis, CMS); Prof Staff Mem, (House Ways/Means C); Pol Dir (White House); Pol Dir (HHS Office of Health Reform-detailed to White House); Pol Adv (Rep. Emanuel); Health LA (Rep. McCarthy)LISA GOLDMAN ●NEW— Sr Counsel, House Comm on Energy & Commerce; Chief Counsel, Sr Counsel (E&C Subcommittee on Consumer Protection & Commerce); Counsel House Comm on E&CMICHAEL ROBINSON ●NEW— Mem Svcs & Coalitions Dir (House Approp C); Pol Adv/Dep CoS (House Maj Ldr DeLay); LD (Rep. Rogers); Sr LA (Rep. Regula); Sr LA (Rep. Franks); LA (Rep. Rogers); Special Proj Asst (House Trans/Infra C); Staff Asst (Rep. Shuster)NAVEEN PARMAR ●NEW— Chief Counsel (Sen. Hickenlooper); General Counsel (House Comm on Sm Bus/Velazquez); Tax Counsel, (House Comm on Sm Bus/Velazquez); Economic Policy Counsel (Sen. Amy Klobuchar); Ways and Means Counsel (Rep. Lloyd Doggett)NICHOLE DISTEFANO ●NEW— LD, Sr Csl, Csl (Senator McCaskill); Assoc Admin, Dep Assoc Admin, Sr Adv (Office of Cong & Intergvt Relations, EPA)PAUL THORNELL ●NEW— Dep Dir of Legis. Affairs (Office of VP Gore); Assoc Dir-Senate Dem Steering Comm (Senator Daschle)ROSEMARY GUTIERREZ ●NEW— Dep COS, Leg Dir (Senator Cantwell); Prof staff, US Small Business Comm; Foreign Affairs Leg. Asst., (Senator Harkin)SAGE EASTMAN ●NEW— Strategy Dir, Dep Staff Dir (Maj), Sr Adv (House Ways/Means C); Comm Dir (Rep. Camp)STEPHEN COTE ●NEW— Staff Dir/Shrd Emp (House Fin Srvs/McHenry), Staff Dir, Dpt. Staff Dir, Sr. Pro Staff, Asst to L Diaz Balart (House Rules), Pol Coord Maj (House Homeland), Assoc Dir, Dpty Assoc Dir (OMB), CoS-DC, LD, LA (L Diaz Balart), LA, Staff Asst (Sen C. Mack)ZACHARY MALLOVE ●NEW— Sr Pol Adv, LA, Leg. Aide (Senator Murray); Leg. Aide, Joint Comm on Deficit Reduc.
IDs
Filing UUID:1404f8ef-0343-4a88-a37e-f6c238ca62fb
Registrant ID:284950
Client ID:68552
2025-08-28
CONTINENTAL STRATEGY, LLC
NRX PHARMACEUTICALS
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
Advocate for lifesaving treatments.
Registered Lobbyists (2)
CRAIG CARBONE ●NEW— Chief of Staff to Sen. Rick ScottTIMOTHY COSTA ●NEW— Chief of Staff to Dan Meuser
IDs
Filing UUID:84c4660d-f8dd-4de1-a1f3-0189b9e4a9b7
Registrant ID:401106285
Client ID:68511
2025-08-24
FIRST PRINCIPLES STRATEGIES, LLC
AMERICAN LABORATORIES PHARMA, LLC
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
Manufacturing Domestic Supply Reforms
Registered Lobbyists (1)
JOSEPH MURRAY ●NEW— Republican Study Committee; Rep. Mark Meadows; & Senator Ron Johnson
IDs
Filing UUID:dce76316-99cd-4f1e-84c7-d1869397d158
Registrant ID:401104348
Client ID:68482
2025-08-14
MARBLE ARCH
ON DEMAND PHARMACEUTICALS
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
Issues relating to securing the domestic pharmaceutical supply chain, ensuring reliable access to essential medications, and manufacturing of high-quality generic drugs in America.
Registered Lobbyists (1)
EMMA DOYLE ●NEW— Principal Deputy White House Chief of Staff; Deputy Chief of Staff for Policy to the First Lady; Chief of Staff, OMB; Acting Chief of Staff, CFPB; Legislative Assistant to Rep. Mick Mulvaney; Legislative Correspondent, Sen. Pat Toomey
IDs
Filing UUID:60e81f6f-eea3-4dd4-982b-9c36dc7943df
Registrant ID:401109131
Client ID:68395
2025-08-03
LMH STRATEGIC SOLUTIONS
REGENXBIO INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.; Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.
Registered Lobbyists (1)
ALANNA TEMME ●NEW— Legislative Director, U.S. Representative Jon Porter
IDs
Filing UUID:37ecf87d-1698-44bb-bdcf-8eeb517d0e8c
Registrant ID:401108183
Client ID:68269
2025-07-28
THE MCMANUS GROUP
BRISTOL-MYERS SQUIBB
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
General issues related to pharmaceuticals
Registered Lobbyists (1)
JOHN MCMANUS ●NEW
IDs
Filing UUID:2faca55d-118f-4ac2-a48b-b8fd2322bfe4
Registrant ID:286096
Client ID:68220
2025-07-15
LMH STRATEGIC SOLUTIONS
ARDELYX, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.; Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.
Registered Lobbyists (1)
ALANNA TEMME ●NEW— Legislative Director, U.S. Representative Jon Porter
IDs
Filing UUID:8e369302-0b49-4b42-8279-d61d7d65f1a6
Registrant ID:401108183
Client ID:67830
2025-07-15
LMH STRATEGIC SOLUTIONS
EXELIXIS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.; Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.
Registered Lobbyists (1)
ALANNA TEMME ●NEW— Legislative Director, U.S. Representative Jon Porter
IDs
Filing UUID:9ffdb0b8-9535-4c2a-b020-b1f05a1be647
Registrant ID:401108183
Client ID:67831
2025-07-15
LMH STRATEGIC SOLUTIONS
HARMONY BIOSCIENCES
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.; Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.
Registered Lobbyists (1)
ALANNA TEMME ●NEW— Legislative Director, U.S. Representative Jon Porter
IDs
Filing UUID:730f8e1e-88d8-435e-9c2d-8fca9582bf9f
Registrant ID:401108183
Client ID:67832
2025-07-15
LMH STRATEGIC SOLUTIONS
INCYTE CORPORATION
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q3
Specific Issues
Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.; Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.
Registered Lobbyists (1)
ALANNA TEMME ●NEW— Legislative Director, U.S. Representative Jon Porter
IDs
Filing UUID:97418d2d-a6e9-4598-a602-3345091bf9c4
Registrant ID:401108183
Client ID:67833
2025-07-14
MERCURY PUBLIC AFFAIRS, LLC
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
$0
$0
Filing Details
Type: ld2 • Year: 2025 Q3
IDs
Filing UUID:5842d0ba-4129-4460-9520-04ebb2d2cc75
Registrant ID:70175
Client ID:64831
2025-07-02
RUBIN, TURNBULL & ASSOCIATES
CHARTWELL
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q2
Specific Issues
Advocating on issues related to pharmaceuticals and pharmaceutical manufacturing.
Registered Lobbyists (2)
HEATHER TURNBULL ●NEWWILLIAM RUBIN ●NEW
IDs
Filing UUID:9f60e65a-8de5-4fc5-88e7-0495068ed95d
Registrant ID:401106132
Client ID:67435
2025-07-02
REPUBLIC CONSULTING, LLC
GRAVITY DIAGNOSTICS
$20,000
$0
Filing Details
Type: ld2 • Year: 2025 Q2
Specific Issues
Monitor policy and budget related to pharmacogenetic testing.
Government Entities
Defense, Dept of (DOD), SENATE
Registered Lobbyists (1)
JODY HOFFMAN
IDs
Filing UUID:552e1436-0d05-4a9f-99f3-6507da4751fd
Registrant ID:401016871
Client ID:54981
2025-07-02
REPUBLIC CONSULTING, LLC
GRAVITY DIAGNOSTICS
$20,000
$0
Filing Details
Type: ld2 • Year: 2025 Q2
Specific Issues
Monitor policy and budget related to pharmacogenetic testing.
Government Entities
Defense, Dept of (DOD), SENATE
Registered Lobbyists (1)
JODY HOFFMAN
IDs
Filing UUID:228319ab-3798-4a03-9e5b-c0fe856950f6
Registrant ID:401016871
Client ID:54981
2025-07-01
CRANE STRATEGIES
REGENERON PHARMACEUTICALS, INC.
$50,000
$0
Filing Details
Type: ld2 • Year: 2025 Q2
Specific Issues
Biodefense funding
Government Entities
Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
STEVEN CRANE — Staff assistant, Senator Barbara Mikulski
IDs
Filing UUID:c38ff6de-9193-4b2f-a63d-0a5cc8471a4a
Registrant ID:400927689
Client ID:196249
2025-07-01
TAUZIN STRATEGIC NETWORKS
RAZORMETRICS
$37,500
$0
Filing Details
Type: ld2 • Year: 2025 Q2
Specific Issues
Lowering Medicare & Medicaid pharmaceutical spend with advanced cost containment systems; Lowering Medicare & Medicaid pharmaceutical spend with advanced cost containment systems
Government Entities
Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
W.J. TAUZIN
IDs
Filing UUID:cdf566d8-c965-4ecd-a053-7fa4564c994b
Registrant ID:400786367
Client ID:64818
2025-07-01
DA VINCI GROUP
BOESEN & SNOW, LLC
$10,000
$0
Filing Details
Type: ld2 • Year: 2025 Q2
Specific Issues
Health Care Issues and pharmaceutical-related issues, generally; No Specific legislation during this period.
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
MARK SMITH
IDs
Filing UUID:e996d85d-f639-4db3-87a9-5dc9193840f1
Registrant ID:11548
Client ID:56318
2025-07-01
ELITE STRATEGIC SERVICES
CONSERVATIVES FOR PROPERTY RIGHTS
$15,000
$0
Filing Details
Type: ld2 • Year: 2025 Q2
Specific Issues
S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498 as drug price controls to expropriate patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution; S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation timing H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-08607; H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act); S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act); Executive Order 14192, Unleashing Prosperity Through Deregulation H. Res. 294 provisions related to proxy voting; Special 301 Report - bolstering U.S. advocacy abroad for respecting intellectual property rights U.S. Trade Representative Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation (Docket No. USTR-2025-0011); H. J. Res. 88, revoking pursuant to the Congressional Review Act California waivers from the Clean Air Act Reform of the definition of the Waters of the United States (WOTUS) under the Clean Water Act
Government Entities
Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Centers For Medicare and Medicaid Services (CMS), U.S. Trade Representative (USTR), Army, Dept of (Corps of Engineers), Environmental Protection Agency (EPA), Small Business Administration (SBA)
Registered Lobbyists (1)
JAMES EDWARDS — LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee
IDs
Filing UUID:4fff56ad-83fc-4791-97dd-562ed3eee966
Registrant ID:401108852
Client ID:61568
2025-07-01
BALLARD PARTNERS
NOVO NORDISK INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q2
Specific Issues
Guidance regarding pharmaceutical regulations.
Registered Lobbyists (3)
BRIAN BALLARD ●NEWMONICA RODRIGUEZ ●NEWSYLVESTER LUKIS ●NEW
IDs
Filing UUID:6890bfed-e777-43de-84d8-e52df1efc6cb
Registrant ID:401104288
Client ID:67420
2025-07-01
E3 STRATEGIC CONSULTING GROUP
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
$50,000
$0
Filing Details
Type: ld2 • Year: 2025 Q2
Specific Issues
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
PATRICK FOLEY
IDs
Filing UUID:f0f4bac9-f255-48cb-a50f-0a9666ec0ff5
Registrant ID:401104104
Client ID:200765
2025-06-30
STANTON PARK GROUP
KYOWA KIRIN
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q2
Specific Issues
FDA modernization policy issues; General issues related to rare disease and clinical trials; General issues related to diagnostics for patients with rare diseases; Issues related to drug pricing; Issues related to reform of pharmacy benefit managers; Issues related to trade; Issues related to Newborn Screening and Genetic Testing;; FDA modernization policy issues; General issues related to rare disease and clinical trials; General issues related to diagnostics for patients with rare diseases; Issues related to drug pricing; Issues related to reform of pharmacy benefit managers; Issues related to trade; Issues related to Newborn Screening and Genetic Testing;
Registered Lobbyists (5)
AISLING MCDONOUGH ●NEW— Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian SchatzBRYAN WELLS ●NEW— Policy Advisor, Sen. Pat RobertsJAMES DERDERIAN ●NEW— Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom BlileyJOSEPH RACHINSKY ●NEWVALERIE HENRY ●NEW— Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo
IDs
Filing UUID:d4b3502a-85a6-42a8-857b-4e03d8177c00
Registrant ID:83717
Client ID:67358
2025-06-27
PARATEK PHARMACEUTICALS
PARATEK PHARMACEUTICALS
$0
$20,000
Filing Details
Type: ld2 • Year: 2025 Q2
Specific Issues
FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
Government Entities
Defense, Dept of (DOD), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
BENJAMIN NOVAK
IDs
Filing UUID:57c39237-8724-496e-9b83-69dbbf8c8e88
Registrant ID:401109327
Client ID:64825
2025-06-25
CONTINENTAL STRATEGY, LLC
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q2
Specific Issues
policy issues related to drug pricing, payment policy, and regulatory oversight.; policy issues related to drug pricing, payment policy, and regulatory oversight.
Registered Lobbyists (2)
CHRISTOPHER MILES ●NEW— Deputy Chief of Staff to Carlos CurbeloTIMOTHY COSTA ●NEW
IDs
Filing UUID:bf0e45d0-9725-490a-bc47-50244ba24450
Registrant ID:401106285
Client ID:67288
2025-06-24
CAROL G HOLLADAY & ASSOCIATES
PHARMADVA
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q2
Specific Issues
Medical Device tariff impacts, expanding access for new medical technology within the VA, S. 1874 Nursing Workforce Reauthorization Act, section 3 - strengthening capacity for Nurse Education & Practices, expand the types of equipment and telehealth technologies the bill supports.; Medical Device tariff impacts, expanding access for new medical technology within the VA, S. 1874 Nursing Workforce Reauthorization Act, section 3 - strengthening capacity for Nurse Education & Practices, expand the types of equipment and telehealth technologies the bill supports.
Registered Lobbyists (1)
CAROL GRAVES HOLLADAY ●NEW
IDs
Filing UUID:7683f8e8-315c-4812-9184-130e512418f5
Registrant ID:401106369
Client ID:67276
2025-06-23
BALLARD PARTNERS
RIO BIOPHARMACEUTICALS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q2
Specific Issues
Assisting with applications before the Food & Drug Administration for generic pharmaceutical approvals.
Registered Lobbyists (4)
ALISON ANWAY ●NEW— LA to Senator Pat Roberts 2006-2010BRIAN BALLARD ●NEWJOSE DIAZ ●NEWSYLVESTER LUKIS ●NEW